Physician profile

Maia Eng

Cardiovascular Disease · Napa, CA

NPI 1043604515

$29,389.08

in general payments reported to CMS, 2019-2025

29 companies · $2,172 in 2025

The $2,172 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$7,981.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $12,625.22 2019-2025 Mitraclip, Cardiomems
Boston Scientific Corporation $6,616.31 2019-2025 Watchman Flx, Watchman Access System, Synergy
Siemens Medical Solutions USA, INC. $1,534.12 2022
Biotronik INC. $1,465.89 2021-2025 Acticor 7 Vr-T Dx, Amvia Edge
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,137.90 2019-2023 Lifevest
Heartflow, INC. $801.50 2021-2025
W. L. Gore & Associates, INC. $591.21 2021-2024 Gore Cardioform Septal Occluder
Medtronic, INC. $476.54 2023-2024 Micra, Corevalve Evolut R
Shockwave Medical, INC $469.17 2020-2022
Inari Medical, INC. $397.25 2023-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Edwards Lifesciences Corporation $392.98 2022-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Amgen INC. $368.23 2019-2025 Repatha, Repatha
Abiomed $339.95 2019-2021
Chiesi USA, INC. $325.54 2019-2023 Kengreal
Bayer Healthcare Pharmaceuticals INC. $319.74 2024-2025
Show all 29 companies
CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $220.32 2019-2020
Boehringer Ingelheim Pharmaceuticals, INC. $204.92 2019-2024 Jardiance
E.R. Squibb & Sons, L.L.C. $202.50 2019-2024 Camzyos, Eliquis
Teleflex LLC $170.13 2022
Baxter Healthcare $155.47 2023-2025 Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor
Actelion Pharmaceuticals US, INC. $142.23 2025 Uptravi, Opsumit
Novartis Pharmaceuticals Corporation $139.95 2025
Pfizer INC. $82.74 2019-2025
Regeneron Healthcare Solutions, INC. $55.41 2019
Janssen Pharmaceuticals, INC $53.00 2020
Sanofi-Aventis U.S. LLC $46.74 2019-2020
Takeda Pharmaceuticals U.S.A., INC. $26.03 2024 Entyvio
Exact Sciences Corporation $14.05 2023 Cologuard Collection Kit
Novo Nordisk INC $14.04 2025 Ozempic, Rybelsus

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Maia Eng

$29,389.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $2,172 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/4221782/maia-eng

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.